Obstructive sleep apnoe and cardiovascular, heart failure and mortality outcomes with empagliflozin versus placebo in the EMPA-REG OUTCOME trial
29 August 2020 (00:00 - 00:00)
Organised by:
About the speaker
New Haven (United States of America)
1 More presentation in this session
Access the full session
The Event
ESC Congress 2020
29 August - 1 September 2020
You may be interested in
Congress Presentation
Congress Presentation
